EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

New Insights into the Role of Mitochondrial Dysfunction in Diabetic Kidney Disease in the Omics Era

Xiao Ke Liu, Xiao Lan Zhou iD, Wen Rui Xia iD

Diabetes, Metabolic Syndrome and Obesity · 2026-09 · Volume 19 · 1-18

DOI: 10.2147/dmso.s622389 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetes, Metabolic Syndrome and Obesity, 2026-09. Verfasst von Xiao Ke Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic kidney disease (DKD) is a major microvascular complication of diabetes and the leading cause of end-stage renal disease worldwide. Accumulating evidence identifies mitochondrial dysfunction as a central driver of DKD progression by linking metabolic reprogramming, oxidative stress, and inflammatory responses. Recent advances in spatial omics, genomics, transcriptomics, proteomics, metabolomics, and microbiome analyses have enabled the characterization of cell-specific and dynamic alterations in mitochondrial function and their interactions with the renal microenvironment. Integrative analyses across these molecular layers have revealed key mechanisms involving mitochondrial quality control, metabolic reprogramming, and inflammatory signaling, while identifying potential biomarkers and therapeutic targets. Furthermore, these approaches have provided mechanistic insights into the renoprotective effects of conventional therapies and bioactive compounds from traditional Chinese medicine. This integrative review synthesizes current evidence to clarify the role of mitochondrial dysfunction in DKD pathogenesis and discusses emerging opportunities for biomarker discovery and precision therapeutics.

Schlagwörter

Stichwörter der Autor:innen

diabetic kidney diseasediagnostic biomarkersmitochondrial dysfunctionmulti-omicsspatialomics

Autor:innen und Institutionen

  • Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.

ORCID-Profile: Xiao Lan Zhou, Wen Rui Xia

Zitieren

APA

Liu, X. K., Zhou, X. L., & Xia, W. R. (2026). New Insights into the Role of Mitochondrial Dysfunction in Diabetic Kidney Disease in the Omics Era. Diabetes, Metabolic Syndrome and Obesity, Volume 19, 1-18. https://doi.org/10.2147/dmso.s622389

Vancouver

Liu XK, Zhou XL, Xia WR. New Insights into the Role of Mitochondrial Dysfunction in Diabetic Kidney Disease in the Omics Era. Diabetes, Metabolic Syndrome and Obesity. 2026;Volume 19:1-18. doi:10.2147/dmso.s622389

BibTeX
@article{Liu2026,
  author = {Liu, Xiao Ke and Zhou, Xiao Lan and Xia, Wen Rui},
  title = {New Insights into the Role of Mitochondrial Dysfunction in Diabetic Kidney Disease in the Omics Era},
  journal = {Diabetes, Metabolic Syndrome and Obesity},
  year = {2026},
  volume = {Volume 19},
  pages = {1--18},
  doi = {10.2147/dmso.s622389}
}
Kostenlos starten →